Global Preventable Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Preventable Vaccines market report explains the definition, types, applications, major countries, and major players of the Preventable Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Serum Institute of India

    • AstraZeneca

    • Protein Sciences

    • Sinovac Biotech

    • Valeant Pharmaceuticals

    • Crucell

    • Bharat Biotech

    • Janssen Pharmaceuticals

    • Baxter

    • Lupin

    • Takeda Pharmaceutical

    • Novartis

    • S K Chemicals

    • Sanofi

    • Dynavax

    • Mitsubishi Tanabe Pharma

    • Shenzhen Kangtai Biological Products

    • GlaxoSmithKline

    • Merck

    • Roche

    • Abbott

    • Panacea Biotec

    • Pfizer

    • Bavarian Nordic

    • LG Life Sciences

    By Type:

    • Adult Preventable Vaccines

    • Pediatric Preventable Vaccines

    By End-User:

    • Bacterial Diseases

    • Virus Diseases

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Preventable Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Preventable Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Preventable Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Preventable Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Preventable Vaccines Market- Recent Developments

    • 6.1 Preventable Vaccines Market News and Developments

    • 6.2 Preventable Vaccines Market Deals Landscape

    7 Preventable Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Preventable Vaccines Key Raw Materials

    • 7.2 Preventable Vaccines Price Trend of Key Raw Materials

    • 7.3 Preventable Vaccines Key Suppliers of Raw Materials

    • 7.4 Preventable Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Preventable Vaccines Cost Structure Analysis

      • 7.5.1 Preventable Vaccines Raw Materials Analysis

      • 7.5.2 Preventable Vaccines Labor Cost Analysis

      • 7.5.3 Preventable Vaccines Manufacturing Expenses Analysis

    8 Global Preventable Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Preventable Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Preventable Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Preventable Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Preventable Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Adult Preventable Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pediatric Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • 9.2 Global Preventable Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Bacterial Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Virus Diseases Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Preventable Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Preventable Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Preventable Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Preventable Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Preventable Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Preventable Vaccines Consumption (2017-2022)

      • 10.3.2 UK Preventable Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Preventable Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Preventable Vaccines Consumption (2017-2022)

      • 10.3.5 France Preventable Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Preventable Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Preventable Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Preventable Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Preventable Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Preventable Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Preventable Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Preventable Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Preventable Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Preventable Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Preventable Vaccines Consumption (2017-2022)

      • 10.4.3 India Preventable Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Preventable Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Preventable Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Preventable Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Preventable Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Preventable Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Preventable Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Preventable Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Preventable Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Preventable Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Preventable Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Preventable Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Preventable Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Preventable Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Preventable Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Preventable Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Preventable Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Preventable Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Preventable Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Preventable Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Preventable Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Preventable Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Preventable Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Preventable Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Preventable Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Preventable Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Preventable Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Preventable Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Preventable Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Preventable Vaccines Consumption (2017-2022)

    11 Global Preventable Vaccines Competitive Analysis

    • 11.1 Serum Institute of India

      • 11.1.1 Serum Institute of India Company Details

      • 11.1.2 Serum Institute of India Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Serum Institute of India Preventable Vaccines Main Business and Markets Served

      • 11.1.4 Serum Institute of India Preventable Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 AstraZeneca

      • 11.2.1 AstraZeneca Company Details

      • 11.2.2 AstraZeneca Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 AstraZeneca Preventable Vaccines Main Business and Markets Served

      • 11.2.4 AstraZeneca Preventable Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Protein Sciences

      • 11.3.1 Protein Sciences Company Details

      • 11.3.2 Protein Sciences Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Protein Sciences Preventable Vaccines Main Business and Markets Served

      • 11.3.4 Protein Sciences Preventable Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Sinovac Biotech

      • 11.4.1 Sinovac Biotech Company Details

      • 11.4.2 Sinovac Biotech Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Sinovac Biotech Preventable Vaccines Main Business and Markets Served

      • 11.4.4 Sinovac Biotech Preventable Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Valeant Pharmaceuticals

      • 11.5.1 Valeant Pharmaceuticals Company Details

      • 11.5.2 Valeant Pharmaceuticals Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Valeant Pharmaceuticals Preventable Vaccines Main Business and Markets Served

      • 11.5.4 Valeant Pharmaceuticals Preventable Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Crucell

      • 11.6.1 Crucell Company Details

      • 11.6.2 Crucell Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Crucell Preventable Vaccines Main Business and Markets Served

      • 11.6.4 Crucell Preventable Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Bharat Biotech

      • 11.7.1 Bharat Biotech Company Details

      • 11.7.2 Bharat Biotech Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Bharat Biotech Preventable Vaccines Main Business and Markets Served

      • 11.7.4 Bharat Biotech Preventable Vaccines Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Janssen Pharmaceuticals

      • 11.8.1 Janssen Pharmaceuticals Company Details

      • 11.8.2 Janssen Pharmaceuticals Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Janssen Pharmaceuticals Preventable Vaccines Main Business and Markets Served

      • 11.8.4 Janssen Pharmaceuticals Preventable Vaccines Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Baxter

      • 11.9.1 Baxter Company Details

      • 11.9.2 Baxter Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Baxter Preventable Vaccines Main Business and Markets Served

      • 11.9.4 Baxter Preventable Vaccines Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Lupin

      • 11.10.1 Lupin Company Details

      • 11.10.2 Lupin Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Lupin Preventable Vaccines Main Business and Markets Served

      • 11.10.4 Lupin Preventable Vaccines Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Takeda Pharmaceutical

      • 11.11.1 Takeda Pharmaceutical Company Details

      • 11.11.2 Takeda Pharmaceutical Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Takeda Pharmaceutical Preventable Vaccines Main Business and Markets Served

      • 11.11.4 Takeda Pharmaceutical Preventable Vaccines Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Novartis

      • 11.12.1 Novartis Company Details

      • 11.12.2 Novartis Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Novartis Preventable Vaccines Main Business and Markets Served

      • 11.12.4 Novartis Preventable Vaccines Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 S K Chemicals

      • 11.13.1 S K Chemicals Company Details

      • 11.13.2 S K Chemicals Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 S K Chemicals Preventable Vaccines Main Business and Markets Served

      • 11.13.4 S K Chemicals Preventable Vaccines Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Sanofi

      • 11.14.1 Sanofi Company Details

      • 11.14.2 Sanofi Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Sanofi Preventable Vaccines Main Business and Markets Served

      • 11.14.4 Sanofi Preventable Vaccines Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Dynavax

      • 11.15.1 Dynavax Company Details

      • 11.15.2 Dynavax Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Dynavax Preventable Vaccines Main Business and Markets Served

      • 11.15.4 Dynavax Preventable Vaccines Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Mitsubishi Tanabe Pharma

      • 11.16.1 Mitsubishi Tanabe Pharma Company Details

      • 11.16.2 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Mitsubishi Tanabe Pharma Preventable Vaccines Main Business and Markets Served

      • 11.16.4 Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Shenzhen Kangtai Biological Products

      • 11.17.1 Shenzhen Kangtai Biological Products Company Details

      • 11.17.2 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Shenzhen Kangtai Biological Products Preventable Vaccines Main Business and Markets Served

      • 11.17.4 Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 GlaxoSmithKline

      • 11.18.1 GlaxoSmithKline Company Details

      • 11.18.2 GlaxoSmithKline Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 GlaxoSmithKline Preventable Vaccines Main Business and Markets Served

      • 11.18.4 GlaxoSmithKline Preventable Vaccines Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    • 11.19 Merck

      • 11.19.1 Merck Company Details

      • 11.19.2 Merck Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.19.3 Merck Preventable Vaccines Main Business and Markets Served

      • 11.19.4 Merck Preventable Vaccines Product Portfolio

      • 11.19.5 Recent Research and Development Strategies

    • 11.20 Roche

      • 11.20.1 Roche Company Details

      • 11.20.2 Roche Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.20.3 Roche Preventable Vaccines Main Business and Markets Served

      • 11.20.4 Roche Preventable Vaccines Product Portfolio

      • 11.20.5 Recent Research and Development Strategies

    • 11.21 Abbott

      • 11.21.1 Abbott Company Details

      • 11.21.2 Abbott Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.21.3 Abbott Preventable Vaccines Main Business and Markets Served

      • 11.21.4 Abbott Preventable Vaccines Product Portfolio

      • 11.21.5 Recent Research and Development Strategies

    • 11.22 Panacea Biotec

      • 11.22.1 Panacea Biotec Company Details

      • 11.22.2 Panacea Biotec Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.22.3 Panacea Biotec Preventable Vaccines Main Business and Markets Served

      • 11.22.4 Panacea Biotec Preventable Vaccines Product Portfolio

      • 11.22.5 Recent Research and Development Strategies

    • 11.23 Pfizer

      • 11.23.1 Pfizer Company Details

      • 11.23.2 Pfizer Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.23.3 Pfizer Preventable Vaccines Main Business and Markets Served

      • 11.23.4 Pfizer Preventable Vaccines Product Portfolio

      • 11.23.5 Recent Research and Development Strategies

    • 11.24 Bavarian Nordic

      • 11.24.1 Bavarian Nordic Company Details

      • 11.24.2 Bavarian Nordic Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.24.3 Bavarian Nordic Preventable Vaccines Main Business and Markets Served

      • 11.24.4 Bavarian Nordic Preventable Vaccines Product Portfolio

      • 11.24.5 Recent Research and Development Strategies

    • 11.25 LG Life Sciences

      • 11.25.1 LG Life Sciences Company Details

      • 11.25.2 LG Life Sciences Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.25.3 LG Life Sciences Preventable Vaccines Main Business and Markets Served

      • 11.25.4 LG Life Sciences Preventable Vaccines Product Portfolio

      • 11.25.5 Recent Research and Development Strategies

    12 Global Preventable Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Preventable Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Adult Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Pediatric Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Preventable Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Bacterial Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Virus Diseases Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Preventable Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Preventable Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Preventable Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Preventable Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Preventable Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Preventable Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Preventable Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Preventable Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Preventable Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Preventable Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Preventable Vaccines

    • Figure of Preventable Vaccines Picture

    • Table Global Preventable Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Preventable Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Adult Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatric Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Bacterial Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Virus Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Preventable Vaccines Consumption by Country (2017-2022)

    • Table North America Preventable Vaccines Consumption by Country (2017-2022)

    • Figure United States Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Preventable Vaccines Consumption by Country (2017-2022)

    • Figure Germany Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Preventable Vaccines Consumption by Country (2017-2022)

    • Figure China Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Preventable Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Preventable Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Preventable Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Preventable Vaccines Consumption by Country (2017-2022)

    • Figure Australia Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Preventable Vaccines Consumption and Growth Rate (2017-2022)

    • Table Serum Institute of India Company Details

    • Table Serum Institute of India Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Preventable Vaccines Main Business and Markets Served

    • Table Serum Institute of India Preventable Vaccines Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Preventable Vaccines Main Business and Markets Served

    • Table AstraZeneca Preventable Vaccines Product Portfolio

    • Table Protein Sciences Company Details

    • Table Protein Sciences Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Protein Sciences Preventable Vaccines Main Business and Markets Served

    • Table Protein Sciences Preventable Vaccines Product Portfolio

    • Table Sinovac Biotech Company Details

    • Table Sinovac Biotech Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sinovac Biotech Preventable Vaccines Main Business and Markets Served

    • Table Sinovac Biotech Preventable Vaccines Product Portfolio

    • Table Valeant Pharmaceuticals Company Details

    • Table Valeant Pharmaceuticals Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Preventable Vaccines Main Business and Markets Served

    • Table Valeant Pharmaceuticals Preventable Vaccines Product Portfolio

    • Table Crucell Company Details

    • Table Crucell Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Crucell Preventable Vaccines Main Business and Markets Served

    • Table Crucell Preventable Vaccines Product Portfolio

    • Table Bharat Biotech Company Details

    • Table Bharat Biotech Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bharat Biotech Preventable Vaccines Main Business and Markets Served

    • Table Bharat Biotech Preventable Vaccines Product Portfolio

    • Table Janssen Pharmaceuticals Company Details

    • Table Janssen Pharmaceuticals Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Pharmaceuticals Preventable Vaccines Main Business and Markets Served

    • Table Janssen Pharmaceuticals Preventable Vaccines Product Portfolio

    • Table Baxter Company Details

    • Table Baxter Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Preventable Vaccines Main Business and Markets Served

    • Table Baxter Preventable Vaccines Product Portfolio

    • Table Lupin Company Details

    • Table Lupin Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lupin Preventable Vaccines Main Business and Markets Served

    • Table Lupin Preventable Vaccines Product Portfolio

    • Table Takeda Pharmaceutical Company Details

    • Table Takeda Pharmaceutical Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Preventable Vaccines Main Business and Markets Served

    • Table Takeda Pharmaceutical Preventable Vaccines Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Preventable Vaccines Main Business and Markets Served

    • Table Novartis Preventable Vaccines Product Portfolio

    • Table S K Chemicals Company Details

    • Table S K Chemicals Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table S K Chemicals Preventable Vaccines Main Business and Markets Served

    • Table S K Chemicals Preventable Vaccines Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Preventable Vaccines Main Business and Markets Served

    • Table Sanofi Preventable Vaccines Product Portfolio

    • Table Dynavax Company Details

    • Table Dynavax Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dynavax Preventable Vaccines Main Business and Markets Served

    • Table Dynavax Preventable Vaccines Product Portfolio

    • Table Mitsubishi Tanabe Pharma Company Details

    • Table Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Pharma Preventable Vaccines Main Business and Markets Served

    • Table Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolio

    • Table Shenzhen Kangtai Biological Products Company Details

    • Table Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shenzhen Kangtai Biological Products Preventable Vaccines Main Business and Markets Served

    • Table Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Preventable Vaccines Main Business and Markets Served

    • Table GlaxoSmithKline Preventable Vaccines Product Portfolio

    • Table Merck Company Details

    • Table Merck Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Preventable Vaccines Main Business and Markets Served

    • Table Merck Preventable Vaccines Product Portfolio

    • Table Roche Company Details

    • Table Roche Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Preventable Vaccines Main Business and Markets Served

    • Table Roche Preventable Vaccines Product Portfolio

    • Table Abbott Company Details

    • Table Abbott Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Preventable Vaccines Main Business and Markets Served

    • Table Abbott Preventable Vaccines Product Portfolio

    • Table Panacea Biotec Company Details

    • Table Panacea Biotec Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Panacea Biotec Preventable Vaccines Main Business and Markets Served

    • Table Panacea Biotec Preventable Vaccines Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Preventable Vaccines Main Business and Markets Served

    • Table Pfizer Preventable Vaccines Product Portfolio

    • Table Bavarian Nordic Company Details

    • Table Bavarian Nordic Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic Preventable Vaccines Main Business and Markets Served

    • Table Bavarian Nordic Preventable Vaccines Product Portfolio

    • Table LG Life Sciences Company Details

    • Table LG Life Sciences Preventable Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table LG Life Sciences Preventable Vaccines Main Business and Markets Served

    • Table LG Life Sciences Preventable Vaccines Product Portfolio

    • Figure Global Adult Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatric Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bacterial Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Virus Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Preventable Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Preventable Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Preventable Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Preventable Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Preventable Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Preventable Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Preventable Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Preventable Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Preventable Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.